Best Addiction and Substance Abuse Grants in Puerto Rico

Puerto Rico addiction and substance use researchers can access funding through the National Institutes of Health to test SBIRT/P approaches for adult alcohol, tobacco, and other drug use and misuse. Eligible projects are prospective clinical trials that implement screening, brief intervention, and referral to treatment or prevention in collaboration with healthcare and community partners.

Research institutions and other eligible organizations in Puerto Rico and other U.S. territories can apply for National Institutes of Health SBIRT/P grants to test implementation strategies for alcohol, tobacco, and other drug use and misuse among adults experiencing health disparities. Funding supports prospective, collaborative studies with healthcare and community partners focused on addiction, substance use disorders, and prevention.

Organizations providing research education in addiction and substance use disorders in Puerto Rico can apply for NIH R25 funding to offer skills-development courses and hands-on research experiences. Grants from US Dept. of Health & Human Services: National Institutes of Health support programs that engage diverse and underrepresented trainees in biomedical and behavioral addiction science, with awards up to US $1,250,000.

Clinician scientists seeking intensive training in substance use and substance use disorder research can apply for mentored career development funding, including scholars based in Puerto Rico. Focused on addiction and drug use disorders, the US Dept. of Health & Human Services National Institutes of Health offers K12 institutional awards up to US $750,000 for supervised research and career development.

Researchers and research institutions in Puerto Rico conducting high-priority HIV and substance use studies can apply for up to US $1,500,000 in RM1 funding to support detailed research plans with preliminary data. Projects from basic to clinical and implementation science that address people who use drugs may be eligible through the National Institutes of Health.

Research institutions and eligible organizations in Puerto Rico and other U.S. territories can apply for National Institutes of Health support for time-sensitive pilot, feasibility, or exploratory studies on addiction and substance use disorders, including drug use disorder. NIH provides up to US $275,000 for rapid-response epidemiology and health services research on emerging substance use issues and policy changes.

Research institutions studying tobacco, alcohol, or cannabis policy impacts on health disparities in the U.S. and territories, including Puerto Rico, can apply for National Institutes of Health grants up to US $275,000. Grants from National Institutes of Health help addiction and substance use organizations partner with communities to advance cancer prevention and health equity through policy-focused studies.

Research institutions and similar organizations in Puerto Rico studying tobacco, alcohol, or cannabis policy impacts on addiction and substance use can apply for up to US $2,500,000 from the National Institutes of Health. Funding supports U.S.-based policy research with community engagement to advance health equity, reduce disparities, and promote cancer prevention related to substance use and exposure.

Clinician-focused organizations and training programs in Puerto Rico working in biomedical, behavioral, or clinical research on substance use and substance use disorders can apply for this NIH R25 education award, offering up to US $350,000. Grants from the National Institutes of Health help build research education for current and future clinical researchers and health service providers.

Research institutions and eligible organizations studying addiction and substance use disorders in Puerto Rico can apply for NIH funding to investigate the harmful effects of acute exposure to ultra-potent synthetic opioids and combinations like fentanyl and xylazine. The US Dept. of Health & Human Services offers up to US $1,500,000 for basic, non-clinical R01 research projects.

Doctoral candidates conducting substance use and substance use disorder research in Puerto Rico and other eligible U.S. locations can receive up to US $100,000 to support up to two years of dissertation work. With a mission to advance addiction science, NIH provides dissertation awards for projects aligned with NIDA priorities, including efforts that diversify the research workforce.

Research institutions and partners advancing drug, device, or neurostimulation approaches for mental, substance use, or alcohol use disorders in Puerto Rico can access funding via the National Institutes of Health. Focused on discovery through proof-of-concept, this opportunity supports translational addiction and alcoholism research, including novel ligands and circuit-engagement devices, with strong encouragement for academia–industry collaborations.

The National Cooperative Drug/Device Discovery/Development Groups (NCDDG) program invites applications to foster innovative research in treating mental disorders and substance use issues. This initiative promotes collaboration between academia and industry, supporting diverse, multidisciplinary projects aimed at developing rational therapies and neurostimulation techniques. Applicants are encouraged to submit Letters of Intent 30 days before the proposal deadline to enhance project alignment with funding goals.

The HEAL initiative aims to translate addiction research into practice to combat the opioid crisis and overdose events. It focuses on identifying barriers to reducing substance use and developing scalable, evidence-based interventions. Emphasizing recovery, prevention, and the integration of mental health, the initiative encourages collaboration among experts in various fields. Although applications are not currently solicited, potential applicants are urged to prepare for future opportunities to apply innovative solutions to enhance addiction treatment and prevention efforts.

This NOFO invites applications for innovative research aimed at developing and implementing interventions to prevent and treat substance use disorders (SUDs) and overdose. It encourages studies that can rapidly advance candidate solutions towards regulatory approval or clinical use, while also addressing co-morbid SUDs. The initiative supports a wide range of research including basic, clinical, translational, and implementation strategies to tackle drug misuse and related health issues, such as HIV/AIDS.

The NIH is offering access to biospecimens from the ABCD, HBCD, and PATH studies to promote research on health and disease across a lifetime. This initiative encourages projects that utilize these samples to deepen understanding of genetic and environmental influences, particularly substance exposure. Researchers can submit proposals to maximize the scientific utility of these resources, in alignment with the goals outlined under federal health regulations.

The National Institute on Drug Abuse (NIDA) is launching a specialized entrepreneurship program aimed at life science researchers in the field of substance use disorders (SUD). This initiative will equip researchers with essential skills to transform their innovative ideas into viable products, focusing on aspects such as market evaluation, customer discovery, and intellectual property. The course will be delivered in a hybrid format to engage US-based SUD researchers effectively, fostering collaboration and advancing the field.

Research institutions and other eligible organizations conducting addiction, substance use, or HIV-related pilot studies in Puerto Rico can access funding through the National Institutes of Health. Grants from NIH help develop and test prevention, treatment, recovery, and services interventions, including HIV eradication and implementation science in substance use settings, to prepare for larger research trials.

The Rural Opioid Technical Assistance Centers program aims to provide essential training and technical assistance to combat opioid and stimulant misuse in rural areas. With 10 Regional Centers and a National Coordinating Office, the initiative focuses on high-quality prevention, treatment, and recovery support services for substance use disorders. This program anticipates awarding 11 new grants to enhance community health and safety in addressing polysubstance use challenges.

The HEAL Initiative aims to combat the opioid crisis through action-oriented research that enhances the translation of addiction epidemiology, prevention, treatment, and recovery services into practice. It prioritizes scalable, evidence-based approaches targeting various levels, including individual and community. The initiative supports a range of methods for research deployment, emphasizing collaboration between researchers and decision-makers to improve outcomes for those affected by addiction and related chronic pain.

The Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use initiative aims to enhance prevention services for infectious diseases among people who use drugs (PWUD). It encompasses two components: a biennial survey to assess service gaps and capacity, and increased support for testing and treatment services. The initiative seeks to improve data utilization in service provision, ultimately increasing testing for HBV, HCV, and HIV, and ensuring more PWUD engage in treatment and care.

The Drug-Free Communities (DFC) Support Program, initiated by the Drug-Free Communities Act of 1997, aims to bolster community coalitions dedicated to preventing youth substance use. Funded by the US HHS's Substance Abuse and Mental Health Services Administration (SAMHSA), this program focuses on collaboration among various stakeholders, including government and non-profit entities, to effectively reduce substance abuse among youth and promote protective factors within communities.

The Drug-Free Communities (DFC) Support Program aims to foster collaboration among community coalitions to combat youth substance use. Established by the Drug-Free Communities Act of 1997, it encourages partnerships among various stakeholders, including governmental and non-profit agencies. The program focuses on reducing substance use among youth and promoting protective factors within communities. This funding opportunity is available for those who have completed the initial funding cycle or experienced funding interruptions, supporting their ongoing efforts to create a healthier environment for youth.

The Applied Drug Policy Research Experiences project aims to provide graduate students and recent post-graduates with hands-on research opportunities to support the National Drug Control Strategy. Through rigorous studies and data analyses, this initiative will explore the evolving dynamics of illicit drug supply and usage, assisting public health and safety officials in anticipating drug-related issues and crafting effective responses to safeguard the American public.

The HEAL Initiative aims to identify new druggable targets for pain within the understudied proteome. This funding opportunity invites applications for pilot projects that generate preliminary data and tools for exploring these targets. The initiative seeks to enhance research on understudied proteins related to pain management, providing essential funding for biochemical and biological work. This NOFO is part of the NIH's broader effort to develop novel medications that address various aspects of opioid addiction and its consequences.

The Syringe Service Program Grant, offered by The Comer Family Foundation, aims to enhance harm reduction initiatives by funding syringe access programs across the U.S. These programs provide sterile syringes, education, and support services to mitigate the risks associated with drug use, including HIV and hepatitis transmission. Priority is given to organizations in underserved areas and those led by marginalized communities. Grants are available for operational costs, program development, and staff training, with a focus on sustainability and local partnerships.

The NIAAA Integrative Neuroscience Initiative on Alcoholism (INIA) aims to renew support for two research consortia focusing on the biological mechanisms of excessive alcohol consumption and Alcohol Use Disorder (AUD). By utilizing advanced technologies and fostering collaboration across multiple sites, this initiative seeks to standardize neurofunctional measures and enhance reproducibility in findings. Investigators are encouraged to prepare for future applications to this NOFO, which will utilize the U24 activity code.